UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000024285
Receipt No. R000027977
Official scientific title of the study Does Mechanical Diagnosis and Therapy change the habitual lumbopelvic posture and time of sitting in individuals with low back pain: a pilot study
Date of disclosure of the study information 2016/10/22
Last modified on 2018/04/05 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Does Mechanical Diagnosis and Therapy change the habitual lumbopelvic posture and time of sitting in individuals with low back pain: a pilot study
Title of the study (Brief title) Does Mechanical Diagnosis and Therapy change the habitual lumbopelvic posture and time of sitting in individuals with low back pain: a pilot study
Region
Japan

Condition
Condition Low back pain
Classification by specialty
Orthopedics Rehabilitation medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study will be to preliminarily investigate if interventions based on Mechanical Diagnosis and Therapy (MDT) changes habitual lumbopelvic posture and time of sitting in individual with low back pain, who have reduction of symptoms by mechanical loading in lumbar extension.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Daily posture scores (threshold of very slouched)(%) and time of sitting measured with the LumoBack sensor
Key secondary outcomes Pain intensity will be assessed with the P4 (0-40). The magnitude of disability will be assessed with the Oswestry Disability Index Japanese version, Patient specific functional scale, and the MOS 36-Item Short-Form Health Survey Japanese version. These assessments will be undertaken before the initial MDT intervention, and at the third and sixth weeks after the initial MDT intervention.

Overall improvement will be measured using the Global Perceived Change Scale (GPC) where patients score their perceived change after the treatment on a 7-point scale ranging from: 1 (completely recovered) to 7 (worse than ever) at the third and sixth weeks after the initial MDT intervention.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Participants will wear the LumoBack sensor for one week prior to the initial MDT session. At the initial MDT session, participants will be classified to posterior derangement subgroup or other MDT subgroups.
Individuals in the posterior derangement subgroup will keep wearing the LumoBack sensor for six weeks and undertake MDT assessments and treatments for six weeks. The intervention will be undertaken 1-2 times a week. Postural education in sitting will be undertaken by giving an original McKenzie lumbar roll.
Individuals in the other MDT subgroups will be excluded from the study.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Individuals with low back pain, who will be referred to physical therapy (exercise therapy and manual therapy)
Individuals waiting for MDT management/treatment for more than one week
Individuals using a smart phone or a tablet
Key exclusion criteria Individuals with a history of back surgery
Individuals without symptoms reduction or centralization by loading in the direction of lumbar extension
Target sample size 15

Research contact person
Name of lead principal investigator Hiroshi Takasaki
Organization Saitama Prefectural University
Division name Physical Therapy
Address Sannomiya 820, Koshigaya, Saitama
TEL 0489734706
Email takasaki-hiroshi@spu.ac.jp

Public contact
Name of contact person Hiroshi Takasaki
Organization Saitama Prefectural University
Division name Physical Therapy
Address Sannomiya 820, Koshigaya, Saitama
TEL 0489734706
Homepage URL
Email takasaki-hiroshi@spu.ac.jp

Sponsor
Institute Saitama Prefectural University
Institute
Department

Funding Source
Organization Japan Society for the promotion of science
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 青木中央クリニック(埼玉県)

Other administrative information
Date of disclosure of the study information
2016 Year 10 Month 22 Day

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 10 Month 05 Day
Anticipated trial start date
2016 Year 10 Month 22 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2016 Year 10 Month 04 Day
Last modified on
2018 Year 04 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027977